9,850€
-1,28%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid:
Ask:
Echtzeit-Chart der Astellas Pharma Inc. Aktie
Börsenkurse Astellas Pharma Inc.
| Börse Stuttgart | - | - | - | - | 9,850€ | 0,19% |
| Tradegate | - | - | - | - | 9,562€ | -2,84% |
| Lang & Schwarz | - | - | - | - | 9,675€ | -1,60% |
| Echtzeit Euro | - | - | - | - | 9,850€ | -1,28% |
| Börse Frankfurt | - | - | - | - | 9,488€ | -0,73% |
| gettex | - | - | - | - | 9,660€ | -2,31% |
Profil der Astellas Pharma Inc. Aktie
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.